AZoLifeSciences on MSN1d
Stanford Researchers Find a Molecule That Rivals Ozempic in Weight Loss
BRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...
AZoRobotics on MSN45m
Forget Ozempic—This AI-Found Peptide May Be the Future of Weight Loss
The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...
FoodNavigator22d
Is this GLP-1.2? New generation of weight-loss drugs moving in
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With the potential to significantly change consumer eating habits, they are ...
Healthline16d
9 Hormones That Affect Your Weight — and How to Improve Them
Hormones are the body’s chemical messengers. They facilitate nearly every bodily process, including metabolism, hunger, and fullness. Hormones serve as chemical messengers in your body. Because ...
BMJ21d
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Canada Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with ...
Frontiers27d
Circadian rhythm, glucose metabolism and diabetic complications: the role of glucokinase and the enlightenment on future treatment
The circadian clock, an innate timing mechanism, governs a variety of physiological activities by producing near-24-h cycles in gene expression. These cycles are reflected in patterns of metabolism ...